Please use this identifier to cite or link to this item: http://repository.i3l.ac.id/jspui/handle/123456789/1057
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAprilia, Jovinka-
dc.date.accessioned2024-05-21T08:01:23Z-
dc.date.available2024-05-21T08:01:23Z-
dc.date.issued2024-01-31-
dc.identifier.urihttp://repository.i3l.ac.id/jspui/handle/123456789/1057-
dc.description.abstractFlavivirus is a genus of positive-sense single-stranded RNA viruses that are mostly transmitted through mosquito or tick vectors and are known to be emerging and re-emerging viruses. Some of the significant species that have been reported to cause an outbreak globally include DENV, YFV, WNV, ZIKV and JEV. While some vaccines have been successful in preventing infections caused by certain flaviviruses, specific treatments and vaccines for the majority of flaviviruses are yet to be found. The early process of viral infection requires the binding of the viral surface protein, specifically the envelope protein, to a host cell receptor. Although their mechanism of neuroinvasion is still unknown, flaviviruses, including the aforementioned species, utilize the ubiquitous Glycosaminoglycans (GAGs), particularly heparan sulfate, as attachment factors to bind to the host cell. GAGs are long chains of polysaccharides composed of repeating units of sugar molecules, and there are different types including heparan sulfate, heparin, chondroitin sulfate, dermatan sulfate, and hyaluronic acid. Given the importance of GAGs in viral attachment, a comprehensive understanding of the biology and pathogenesis of flavivirus is crucial in identifying potential treatments. Hence, this study aims to investigate the role of heparin in flavivirus infection on SH-sy5y cells through luciferase assay. The results showed that pre-treating the virus significantly inhibited the infection on SH-sy5y cells. These findings can be beneficial for future references in the discovery of treatments against flavivirus.en_US
dc.language.isoenen_US
dc.publisherIndonesia International Institute for Life Sciencesen_US
dc.relation.ispartofseriesEP BM-010;EP24-052-
dc.subjectFlaivivirusen_US
dc.subjectGlycosaminoglycans (GAGs)en_US
dc.subjectheparinen_US
dc.subjectheparan sulfateen_US
dc.subjectluciferase assayen_US
dc.titleModeling Attachment Factor Used in Flaviviral Entryen_US
dc.typeWorking Paperen_US
Appears in Collections:Biomedicine

Files in This Item:
File Description SizeFormat 
EP2024_BM_Jovinka Aprilia-1.pdf
  Restricted Access
Full text3.35 MBAdobe PDFView/Open Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.